Aroa Biosurgery (ASX:ARX) has announced the appointment of Paul Shearer as a Non-Executive Director, effective immediately, following the retirement of long-serving Director John Pinion after a decade of service.
Mr Shearer is an accomplished global healthcare executive with over 30 years of experience in the medical device industry. He spent two decades as Senior Vice President, Sales and Marketing at Fisher & Paykel Healthcare, where he led international commercial operations across more than 50 markets and played a key role in the company’s U.S. expansion. He also serves as a Director of Skellerup Holdings.
Brian Ward, Chief Executive Officer of Aroa, said the appointment strengthens the company’s international growth strategy. “Paul’s experience leading the international sales growth of a New Zealand-headquartered medical device company, including a strong track record in the United States, will provide valuable insight as Aroa continues to scale,” Dr Ward said. “On behalf of the team at Aroa, I extend a warm welcome to him.”
Mr Pinion, a U.S.-based medtech executive who joined the Board in 2015, will retire on the same date.
Jim McLean, Chair of Aroa’s Board, paid tribute to his contribution.
“On behalf of the Board, I would like to thank John for his significant contribution over the past 10 years,” Mr McLean said. “His experience and insight have helped guide the company through a number of important milestones. We wish him well for the future. I am also pleased to welcome Paul to the Board — he brings deep global commercial experience that will strengthen the Board’s oversight as Aroa continues to execute its growth strategy.”
Mr Shearer will stand for election at Aroa’s next Annual General Meeting.
Founded in 2008 and headquartered in Auckland, Aroa Biosurgery develops regenerative soft-tissue repair products based on its proprietary AROA ECM technology platform, with distribution across more than 50 countries, including the United States. Over seven million Aroa products have been used globally in wound and soft-tissue reconstruction procedures.